Випадок успішної перикардіотомії з дренуванням перикардіальної порожнини в пацієнта з мультиморбідністю

Н.М. Середюк, А.В. Судус, І.М. Будзан, С.М. Гричинюк В.Б. Томин, Н.В. Рогів, М.В. Бєлінський, А.Я. Василишин

Література 

1. Humenyuk AF Aspects of rational treatment of cardiovascular patients with polymorphic lesions. Ukr Med Chasopys. 2009;5(73):25-32. (in Ukr.).
2. Kovalenko VМ. Еra of personalized medicine. Zdorovja Ukrainy. 2017;2(51):64.
3. Campbell-Scherer D. Multimorbidity: a challenge for evidence-based medicine. Evid Based Med. 2010;15(6):165-166. (in Ukr.).
4. Caughey GE, Ramsay EN, Vitry AI. et al. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J Epidemiol Community Health. 2010;64(12):1036-1042.
5. Khan NK, Järvelä KM, Loisa EL. et al. Incidence, presentation and risk factors of late postoperative pericardial effusions requiring invasive treatment after cardiac surgery. Interact Cardiovasc Thorac Surg. 2017;24(6):835-840.
6. Mercer SW, Gunn J, Wyke S. Improving the health of people with multimorbidity: the need for prospective cohort studies. J Comorbidity. 2011;1:4-7.
7. Pepi M, Muratori B, Doria E. et al. Pericardial effusion after cardiac surgery: incidence, size, and haemodynamic. Consequence Brit Heard J. 1994;72(4):327-331.
8. Valderas JM, Starfield B, Sibbald B. et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357-363.
9. You SC, Shim CY, Hong GR. et al. Incidence, predictors and clinical outcomes of postoperative cardiac tamponade in patiens undergoing heart valve surgery. PL os One. 2016;11(11):165-754.